Colorcon logo

Colorcon

North America, Pennsylvania, United States, Harleysville

Description

Colorcon specializes in the design and development of specialty excipients for solid oral dosages for the pharmaceutical.

Investor Profile

Colorcon has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Medical
  • Pharmaceutical
  • Life Science
  • Nutraceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Colorcon frequently co-invest with?

Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Sanabil
Asia, Ar Riyad, Saudi Arabia, Riyadh
Co-Investments: 1
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 1
Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 1
AME Cloud Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
B Capital
North America, California, United States, Manhattan Beach
Co-Investments: 1
Touchdown Ventures
North America, New Jersey, United States, Haddonfield
Co-Investments: 2
DCVC
North America, California, United States, San Francisco
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1

What are some of recent deals done by Colorcon?

MEND

New York, New York, United States

MEND is a life sciences company that focuses on clinical nutrition and medical foods.

BiotechnologyHealth CareLife ScienceNutraceutical
Series AJun 6, 2023
Amount Raised: $15,000,000
Atomwise

San Francisco, California, United States

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalPharmaceutical
Series BAug 11, 2020
Amount Raised: $123,000,000